Swittons Partners With Pharmaceutical Commercial Organizations to Combat the Spread of Coronavirus

Swittons, a P360 company

March 10, 2020

Swittons, a P360 company, is partnering with pharmaceutical commercial organizations to help key healthcare practitioners maintain communication with pharma during this time of global pandemic impact and protective travel restrictions. Swittons’ fully customizable smart device is being offered to physicians for free by participating organizations. In addition, Swittons is providing pharmaceutical commercial organizations with the device for free, for up to three months.

“Swittons is working to limit exposure risk to the Coronavirus, or other pandemics, by eliminating unnecessary visits to hospitals and other healthcare facilities,” stated Swittons CEO and Founder Anupam Nandwana. “By automating the pharma to physician relationship, our goal is that professionals working in the field of pharmaceutical sciences will not be forced to risk their own health, and will not become a serious risk factor for the spread of the virus.”

At the click of a button, Swittons enables physicians to request samples, schedule visits, book medical science liaison (MSL) consultations and access important medical information. This remote communication helps ensure the continuity of business, and also protects pharmaceutical staff from high-risk exposure and further propagation. This is especially important within critical therapeutic areas.

The smart devices can be preprogrammed with individualized functionality, and it comes out of the box ready. Swittons automatically connects through a Wi-Fi or GSM cellular connection (GSM service provided by Swittons).

Post a Comment

You must be logged in to post a Comment.